NEOS Investment Management LLC significantly increased its stake in Biogen Inc. (NASDAQ:BIIB) by 55.7% in the third quarter, holding shares valued at approximately $8.03 million. This increase follows Biogen’s exceeding quarterly earnings expectations with $1.99 EPS and $2.28 billion in revenue, leading to a reaffirmed FY2026 guidance. The stock currently trades around $194, and analysts generally rate it as a “Hold” with an average target price of $205.84, despite mixed institutional investor activity.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
NEOS Investment Management LLC Boosts Position in Biogen Inc. $BIIB
NEOS Investment Management LLC significantly increased its stake in Biogen Inc. (NASDAQ:BIIB) by 55.7% in the third quarter, holding shares valued at approximately $8.03 million. This increase follows Biogen’s exceeding quarterly earnings expectations with $1.99 EPS and $2.28 billion in revenue, leading to a reaffirmed FY2026 guidance. The stock currently trades around $194, and analysts generally rate it as a “Hold” with an average target price of $205.84, despite mixed institutional investor activity.